17 November 2020 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held earlier today, all resolutions were duly passed.
The voting results are included below:
Resolution
For
Against
Discretion to Chairman and Third party
Withheld
Total
01
18,388,598
78
0
8,413
18,397,089
02
17,929,670
466,254
0
1,165
18,397,089
03
18,193,058
203,991
0
40
18,397,089
04
18,383,559
13,490
0
40
18,397,089
05
18,381,954
15,045
0
90
18,397,089
06
18,362,601
34,448
0
40
18,397,089
07
18,385,188
11,861
0
40
18,397,089
08
18,395,139
1,910
0
40
18,397,089
09
18,395,089
1,910
0
90
18,397,089
10
18,397,011
78
0
0
18,397,089
11
13,388,610
4,905,439
0
103,040
18,397,089
12
17,558,096
832,043
0
6,950
18,397,089
13
17,610,875
784,859
0
1,355
18,397,089
14
18,083,871
311,863
0
1,355
18,397,089
15
17,825,190
201,623
0
370,276
18,397,089
Resolution 11
The Board of Directors notes that while Resolution 11 was passed and a majority of over 72% of the votes received were 'for' this resolution, a number of the votes received opposed this resolution.
We will consult with our shareholders in order to understand more fully the reasons for the opposition to this resolution and we will reflect carefully on feedback received from our shareholders.
An update on the consultation process will be made, in accordance with the UK Corporate Governance Code, within six months of the AGM.
For further information, please contact:
Craneware plc
+44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Peel Hunt (NOMAD and Joint Broker)
+44 (0)20 7418 8900
Dan Webster
George Sellar
Andrew Clark
Investec Bank (Joint Broker)
+44 (0)20 7597 5970
Patrick Robb
Sebastian Lawrence
Henry Reast
Alma (Financial PR)
+44 (0)203 405 0205
Caroline Forde
Robyn Fisher
Helena Bogle
Joe Pederzolli
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.
Learn more at www.craneware.com
Attachments
Original document
Permalink
Disclaimer
Craneware plc published this content on 17 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2020 14:42:08 UTC
Craneware plc is a United Kingdom company that is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company is engaged in automated value cycle solutions, including 340B management, collaborates with United States healthcare providers to plan, execute, and monitor operational and financial performance, so they can deliver quality care to their communities. The Company combines revenue integrity, cost management, 340B performance, and decision enablement into a single, software-as-a-service (SaaS)-based platform. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Referral Verification System, Trisus Medication Formulary, Trisus Medication Financial Management, InSight Audit and others.
CRANEWARE PLC 
